Topiramate and Ertugliflozin Interaction

Drug interaction information between Topiramate and Ertugliflozin.

Topiramate and Ertugliflozin have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Topiramate and Ertugliflozin. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Topiramate

Anticonvulsant

Drug B

Ertugliflozin

SGLT2 Inhibitor

How They Interact

Topiramate affects how the body handles acid, which can increase the risk of a serious condition called lactic acidosis when combined with metformin.

FDA Label Information

7 DRUG INTERACTIONS Table 3: Clinically Significant Drug Interactions with SEGLUROMET Carbonic Anhydrase Inhibitors Clinical Impact: The risk of lactic acidosis may increase due to concomitant use of Topiramate or other carbonic anhydrase inhibitors (e.g., zonisamide, acetazolamide or dichlorphenamide) with metformin.

Ertugliflozin Also Interacts With

View all Ertugliflozin interactions →

Frequently Asked Questions

What SPL severity band is on file for Topiramate + Ertugliflozin?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Topiramate has 30 labeled pairs on file vs Ertugliflozin's 8. In the moderate band specifically: Topiramate has 3 (also Zonisamide, Alogliptin); Ertugliflozin has 6 (also Metformin, Dolutegravir, Ranolazine, Cimetidine).

What mechanism field is on file for Topiramate and Ertugliflozin?

Topiramate affects how the body handles acid, which can increase the risk of a serious condition called lactic acidosis when combined with metformin.

Topiramate's labeled portfolio outnumbers Ertugliflozin

SPL source-record counts only. This page's band is moderate · classes on file: Topiramate (Anticonvulsant); Ertugliflozin (SGLT2 Inhibitor).

Topiramate

0 major · 3 moderate · 27 minor · 30 total

Ertugliflozin

0 major · 6 moderate · 2 minor · 8 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.